BioHealth News Archive
Montgomery County Updates: County Welcomes BioNTech to Gaithersburg for U.S. Manufacturing Facility
German-based BioNTech has announced that it will soon be joining Montgomery County’s growing list of world-renowned international companies in the “Immunology Capital Next to…
Read More
Preparing for the Endless Frontier: What Universities, States and Regions Should Do Now While Congress Finalizes Its Plans?
The Endless Frontier bill, now incorporated into the U.S. Innovation and Competition Act, made progress in the U.S. Senate while parallel legislation in the…
Read More
Sponsored | The essential guide to drug commercialization: A manufacturer’s handbook for selecting solutions and partners | BioSpace
You have invested the time, expertise, and financial resources to develop a therapy that changes patient lives for the better. After all of your…
Read More
Matan Companies breaks ground on Progress Labs at Riverside
Matan Companies breaks ground on Progress Labs at Riverside I The City-based project will feature 215,000 square feet of biomanufacturing-ready space -- including a…
Read More
HIV Cure Program Releases Initial Clinical Trial Data | American Gene Technologies
ROCKVILLE, MD, July 15, 2021 /Globe Newswire/ -- American Gene Technologies (AGT) announced today that the Data and Safety Monitoring Board (DSMB) voted unanimously…
Read More
Emergent BioSolutions wins extension on smallpox vaccine deal – Baltimore Business Journal
The extension follows a tumultuous time for the Gaithersburg company, making it unclear if the government would proceed with deals as normal. {iframe}https://www.bizjournals.com/baltimore/news/2021/07/21/emergent-biolsolutions-wins-smallpox-vaccine-deal.html{/iframe}
Read MoreCovid vaccine maker BioNTech buys Gaithersburg manufacturing facility – Washington Business Journal
The German firm hopes to expand its cancer treatments with the purchase. Image: BioNTech is buying a Gaithersburg manufacturing facility on Clopper Road from…
Read More
Immunomic’s Academic Collaborator Dr. John Sampson Recognized as “World Expert” in Glioblastoma as Part of Glioblastoma Awareness Day | Business Wire
ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today that its’…
Read More
BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD · BioBuzz
MAINZ, Germany & SANTA MONICA, Calif.–(BUSINESS WIRE)–BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Kite, a Gilead Company (Nasdaq: GILD, “Kite”) today announced the two companies…
Read MoreAlexandria Plans 200K SF Lab Building To Kick Off Huge Rockville Project
Montgomery County is set to consider plans for the first phase of a five-building life sciences project in Rockville. An affiliate of life sciences…
Read MoreScience Magazine: ARPA-H: Accelerating biomedical breakthroughs | The White House
The biomedical research ecosystem has delivered advances that not long ago would have been inconceivable, exemplified by highly effective COVID-19 vaccines developed by global…
Read More
Game Changers | VT Corporate Research Center
Come join the Virginia Tech Corporate Research Center for Game Changer Week! Game Changer Week, set for August 23-27, 2021 will bring together industry…
Read More
Ascentage Pharma Establishes Cooperative R&D Agreement (CRADA) with the National Cancer Institute for Clinical Development of Ascentage Pharma’s Drug Compound pelcitoclax | BioSpace
SUZHOU, China, and ROCKVILLE, Md., July 19, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers,…
Read More
Join Our Celebration | American Gene Technologies
The Data Safety and Monitoring Board has met and evaluated the safety data from the first participant treated with AGT103-T, our HIV-cure drug candidate.…
Read More
Maryland-based Novavax’s effort to vaccinate the world, from zero to not quite warp speed: ‘This takes time and expertise’ – Baltimore Sun
On a sweltering June morning, Novavax CEO and COVID vaccine maker Stanley Erck stood on a stage unmasked and did something that would have…
Read More